Source: InCrowd Blog

InCrowd Blog Instant Insights – CRISPR

Prescriber Perceptions around CRISPR in 2023 Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.In considering the 2019 research, InCrowd wanted to understand any change in awareness of these therapies and then examine specific perceptions around CRISPR. This research reflects the […] The post Instant Insights – CRISPR appeared first on InCrowd.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Daniel S. Fitzgerald's photo - President & CEO of InCrowd

President & CEO

Daniel S. Fitzgerald

CEO Approval Rating

90/100

Read more